Home › Funds › B. Metzler seel. Sohn & Co. AG › JNJ

B. Metzler seel. Sohn & Co. AG position in JNJ

JOHNSON & JOHNSON · Health Care

B. Metzler seel. Sohn & Co. AG reported holding 298,528 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$79.0M, representing 0.69% of its reported portfolio and ranking #29 among its reported holdings. B. Metzler seel. Sohn & Co. AG has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)298.53K sh
Reported value held$79.03M
Portfolio Weight0.69%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How B. Metzler seel. Sohn & Co. AG's JNJ position evolved

B. Metzler seel. Sohn & Co. AG first disclosed a stake in JNJ in Q3 2023 at 1,037,243 shares (US$161.6M). The position peaked in Q1 2024 at 1,094,744 shares, worth US$174.3M. Across 13 filings, B. Metzler seel. Sohn & Co. AG increased the stake 4 time(s), trimmed it 7 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 298,528 shares valued at US$79.0M — a reduction of -12,062 shares quarter over quarter.. Notable position changes include a 60% trim in Q2 2024 (shares rose 11% over the following quarter), a 33% trim in Q2 2026 (shares rose 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.04M $161.55M New
Q4 2023 1.02M $160.45M Reduce
Q1 2024 1.09M $174.31M Add
Q2 2024 439.59K $64.25M Reduce
Q3 2024 444.58K $72.05M Add
Q4 2024 436.45K $63.09M Reduce
Q1 2025 442.86K $73.44M Add
Q2 2025 443.71K $67.78M Hold
Q3 2025 434.69K $80.60M Reduce
Q4 2025 480.15K $99.36M Add
Q1 2026 460.39K $112.54M Reduce
Q2 2026 310.59K $78.88M Reduce
Q3 2026 298.53K $79.03M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has B. Metzler seel. Sohn & Co. AG held JNJ?

B. Metzler seel. Sohn & Co. AG has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is B. Metzler seel. Sohn & Co. AG's current position in JNJ?

As of Q3 2026, B. Metzler seel. Sohn & Co. AG holds 298.53K shares of JNJ (JOHNSON & JOHNSON), valued at $79.03M, representing 0.69% of its reported portfolio and ranking #29.

Has B. Metzler seel. Sohn & Co. AG been buying or selling JNJ?

In the latest 13F filing (Q3 2026), B. Metzler seel. Sohn & Co. AG reduced its position in JNJ. The position peaked in Q1 2024 at 1.09M shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.